RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

CUSIP: 75629V104

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A Common Stock
Shares outstanding
514,715,255
Total 13F shares
304,544,141
Share change
+39,617,419
Total reported value
$2,058,776,356
Put/Call ratio
129%
Price per share
$6.76
Number of holders
310
Value change
+$268,240,445
Number of buys
177
Number of sells
93

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q4 2024

As of 31 Dec 2024, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 310 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 304,544,141 shares. The largest 10 holders included VANGUARD GROUP INC, ARK Investment Management LLC, BAILLIE GIFFORD & CO, BlackRock, Inc., SOFTBANK GROUP CORP., Mubadala Investment Co PJSC, STATE STREET CORP, Kinnevik AB (publ), Novo Holdings A/S, and MIC Capital Management UK LLP. This page lists 314 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.